$LOPE
Grand Canyon Education, Inc.

2024 Q2 Form 10-Q Financial Statement

#000155837024007046 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $227.5M $274.7M
YoY Change 8.02% 9.82%
Cost Of Revenue $119.1M $122.0M
YoY Change 6.97% 10.06%
Gross Profit $108.4M $152.7M
YoY Change 9.2% 9.62%
Gross Profit Margin 47.64% 55.58%
Selling, General & Admin $63.53M $66.08M
YoY Change 3.0% 5.43%
% of Gross Profit 58.63% 43.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.033M $8.758M
YoY Change 20.33% 14.6%
% of Gross Profit 8.34% 5.74%
Operating Expenses $63.53M $66.08M
YoY Change -0.4% 5.43%
Operating Profit $42.72M $84.48M
YoY Change 20.53% 13.43%
Interest Expense $4.110M $2.000K
YoY Change 59.12% -89.47%
% of Operating Profit 9.62% 0.0%
Other Income/Expense, Net
YoY Change
Pretax Income $46.83M $88.21M
YoY Change 23.15% 15.13%
Income Tax $11.95M $20.20M
% Of Pretax Income 25.52% 22.9%
Net Earnings $34.88M $68.01M
YoY Change 20.38% 14.18%
Net Earnings / Revenue 15.33% 24.76%
Basic Earnings Per Share $1.19 $2.31
Diluted Earnings Per Share $1.19 $2.29
COMMON SHARES
Basic Shares Outstanding 29.74M 30.02M
Diluted Shares Outstanding 29.42M 29.64M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $341.8M $290.7M
YoY Change 46.47% 49.44%
Cash & Equivalents $241.3M $196.2M
Short-Term Investments $100.5M $94.49M
Other Short-Term Assets $13.05M $16.51M
YoY Change 4.74% 4.32%
Inventory
Prepaid Expenses
Receivables $29.45M $111.7M
Other Receivables $5.504M $25.54M
Total Short-Term Assets $389.8M $444.5M
YoY Change 39.45% 40.7%
LONG-TERM ASSETS
Property, Plant & Equipment $173.8M $172.2M
YoY Change -24.8% 14.49%
Goodwill $160.8M $160.8M
YoY Change 0.0% 0.0%
Intangibles $164.2M $166.3M
YoY Change -4.88% -4.82%
Long-Term Investments
YoY Change
Other Assets $2.209M $1.755M
YoY Change 2.41% -10.6%
Total Long-Term Assets $602.9M $591.1M
YoY Change 6.39% 5.91%
TOTAL ASSETS
Total Short-Term Assets $389.8M $444.5M
Total Long-Term Assets $602.9M $591.1M
Total Assets $992.7M $1.036B
YoY Change 17.31% 18.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.47M $29.83M
YoY Change -1.65% 36.81%
Accrued Expenses $31.94M $57.61M
YoY Change -53.32% 81.95%
Deferred Revenue $7.216M $10.27M
YoY Change -20.79% 6.12%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $107.5M $160.1M
YoY Change 6.99% 33.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.538M $1.583M
YoY Change -97.89% 269.0%
Total Long-Term Liabilities $1.538M $1.583M
YoY Change -97.89% 269.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $107.5M $160.1M
Total Long-Term Liabilities $1.538M $1.583M
Total Liabilities $233.5M $276.1M
YoY Change 16.29% 28.57%
SHAREHOLDERS EQUITY
Retained Earnings $2.348B $2.313B
YoY Change 10.31% 10.17%
Common Stock $330.5M $326.5M
YoY Change 4.44% 4.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $759.2M $759.4M
YoY Change
Total Liabilities & Shareholders Equity $992.7M $1.036B
YoY Change 17.31% 18.48%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $34.88M $68.01M
YoY Change 20.38% 14.18%
Depreciation, Depletion And Amortization $9.033M $8.758M
YoY Change 20.33% 14.6%
Cash From Operating Activities $98.56M $84.96M
YoY Change 4.71% 34.86%
INVESTING ACTIVITIES
Capital Expenditures $9.052M $9.051M
YoY Change -2.2% 2.49%
Acquisitions
YoY Change
Other Investing Activities -$5.677M $3.791M
YoY Change 240.55% -113.39%
Cash From Investing Activities -$14.73M -$5.260M
YoY Change 34.84% -85.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -38.72M -29.97M
YoY Change -14.55% -27.32%
NET CHANGE
Cash From Operating Activities 98.56M 84.96M
Cash From Investing Activities -14.73M -5.260M
Cash From Financing Activities -38.72M -29.97M
Net Change In Cash 45.11M 49.73M
YoY Change 19.07% -423.59%
FREE CASH FLOW
Cash From Operating Activities $98.56M $84.96M
Capital Expenditures $9.052M $9.051M
Free Cash Flow $89.51M $75.91M
YoY Change 5.46% 40.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001434588
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-34211
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
GRAND CANYON EDUCATION, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3356009
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2600 W. Camelback Road
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Phoenix
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85017
CY2024Q1 dei City Area Code
CityAreaCode
602
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
247-4400
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2024Q1 dei Trading Symbol
TradingSymbol
LOPE
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29738382
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
274675000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
250125000
CY2024Q1 lope Technology And Academic Services
TechnologyAndAcademicServices
39125000
CY2023Q1 lope Technology And Academic Services
TechnologyAndAcademicServices
37512000
CY2024Q1 lope Counseling Services And Support
CounselingServicesAndSupport
82884000
CY2023Q1 lope Counseling Services And Support
CounselingServicesAndSupport
73349000
CY2024Q1 us-gaap Marketing Expense
MarketingExpense
55353000
CY2023Q1 us-gaap Marketing Expense
MarketingExpense
52894000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10730000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9788000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2105000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2105000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
190197000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
175648000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
84478000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
74477000
CY2024Q1 us-gaap Interest Expense
InterestExpense
2000
CY2023Q1 us-gaap Interest Expense
InterestExpense
19000
CY2024Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3729000
CY2023Q1 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2153000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
88205000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
76611000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20195000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17047000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
68010000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
59564000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.31
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.96
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.29
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.94
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29459000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30461000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29639000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30638000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
196208000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146475000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
94485000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
98031000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
111710000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78811000
CY2024Q1 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
25500000
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
38000
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1316000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
16512000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
12889000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
444453000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
337522000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
172186000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169699000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
90135000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
92454000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
166276000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
168381000
CY2024Q1 us-gaap Goodwill
Goodwill
160766000
CY2023Q4 us-gaap Goodwill
Goodwill
160766000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1755000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1641000
CY2024Q1 us-gaap Assets
Assets
1035571000
CY2023Q4 us-gaap Assets
Assets
930463000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
29827000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17676000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24785000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31358000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57608000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26725000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
26300000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
10250000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10270000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11336000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11024000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
160126000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
97033000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28454000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26749000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1583000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
410000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
85961000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
88257000
CY2024Q1 us-gaap Liabilities
Liabilities
276124000
CY2023Q4 us-gaap Liabilities
Liabilities
212449000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54087000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
53970000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29839000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29953000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
541000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
540000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
24248000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
24017000
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1879697000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1849693000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
325994000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
322512000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-113000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-57000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2312722000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2244712000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
759447000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
718014000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1035571000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
930463000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
68010000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
59564000
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
18000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
37000
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-56000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
119000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
67954000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
59683000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
718014000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
67954000
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
22558000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3963000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
759447000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
637619000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
59683000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
35090000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-2962000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
659250000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
68010000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
59564000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3483000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3369000
CY2024Q1 lope Depreciation And Amortization Excluding Intangible Assets
DepreciationAndAmortizationExcludingIntangibleAssets
6653000
CY2023Q1 lope Depreciation And Amortization Excluding Intangible Assets
DepreciationAndAmortizationExcludingIntangibleAssets
5537000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2105000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2105000
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1724000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1816000
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
208000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-410000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32899000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25158000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3757000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4625000
CY2024Q1 lope Increase Decrease In Operating Lease Liabilities Recognized In Exchange For Right Of Use Assets
IncreaseDecreaseInOperatingLeaseLiabilitiesRecognizedInExchangeForRightOfUseAssets
335000
CY2023Q1 lope Increase Decrease In Operating Lease Liabilities Recognized In Exchange For Right Of Use Assets
IncreaseDecreaseInOperatingLeaseLiabilitiesRecognizedInExchangeForRightOfUseAssets
419000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
11970000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1953000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-51000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6294000
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
17328000
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
14225000
CY2024Q1 lope Increase Decrease In Contract With Customer Liability Excluding Student Deposits
IncreaseDecreaseInContractWithCustomerLiabilityExcludingStudentDeposits
10270000
CY2023Q1 lope Increase Decrease In Contract With Customer Liability Excluding Student Deposits
IncreaseDecreaseInContractWithCustomerLiabilityExcludingStudentDeposits
9678000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84963000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
62999000
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8979000
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8587000
CY2024Q1 lope Payments To Develop Education Resources
PaymentsToDevelopEducationResources
72000
CY2023Q1 lope Payments To Develop Education Resources
PaymentsToDevelopEducationResources
244000
CY2024Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
19381000
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
52556000
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
23172000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
24253000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5260000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37134000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
29970000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
41234000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29970000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-41234000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49733000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-15369000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
146475000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
120409000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
196208000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105040000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
2000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
19000
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
295000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
230000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2091000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
973000
CY2024Q1 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
25500000
CY2024Q1 lope Excise Tax Treasury Stock Repurchases
ExciseTaxTreasuryStockRepurchases
34000
CY2023Q1 lope Excise Tax Treasury Stock Repurchases
ExciseTaxTreasuryStockRepurchases
187000
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 6pt 0pt;">1. Nature of Business</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;">Grand Canyon Education, <span style="white-space:pre-wrap;">Inc. (together with its subsidiaries, the “Company” or “GCE”) is a publicly traded education services company dedicated to serving colleges and universities. GCE has developed significant technological solutions, infrastructure and operational processes to provide services to these institutions on a large scale. GCE’s most significant university partner is Grand Canyon University (“GCU”), an Arizona non-profit corporation, a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases and certificates across </span>ten colleges both online, on ground at its campus in Phoenix, Arizona and at six off-campus classroom and laboratory sites.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;"><span style="white-space:pre-wrap;">We also provide education services to numerous university partners across the United States. GCE has continued to add additional university partners. In the healthcare field, we work in partnership with a growing number of top universities and healthcare networks across the country, offering healthcare-related academic programs at off-campus classroom and laboratory sites located near healthcare providers and developing high-quality, career-ready graduates who enter the workforce ready to meet the demands of the healthcare industry. In addition, we have provided certain services to a university partner to assist them in expanding their online graduate programs. As of March 31, 2024, GCE provides education services to </span>23 university partners across the United States.</p>
CY2024Q1 lope Number Of University Service Partners
NumberOfUniversityServicePartners
23
CY2024Q1 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
25500000
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2024Q1 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
2956000
CY2023Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
188000
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 6pt 0pt;">Concentration of Credit Risk </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;">The Company believes the credit risk related to cash equivalents and investments is limited due to its adherence to an investment policy that requires investments to have a minimum BBB rating, depending on the type of security, by at least one major rating agency at the time of purchase. All of the Company’s cash equivalents and investments as of March 31, 2024 and December 31, 2023 consist of investments rated BBB or higher by at least one rating agency. Additionally, the Company utilizes at least one financial institution to conduct initial and ongoing credit analysis on its investment portfolio to monitor and lower the potential impact of market risk associated with its cash equivalents and investment portfolio. Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash balances, which are primarily invested in money market funds or on deposit at high credit quality financial institutions in the U.S. Accounts at each institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. At March 31, 2024 and December 31, 2023, the Company had $195,207 and $145,474, respectively, in excess of the FDIC insured limit. The Company is also subject to credit risk for its accounts receivable balance. Our dependence on our most significant university partner, with 89.7% and 88.5% of total service revenue for the three-month periods ended March 31, 2024 and 2023, respectively, subjects us to the risk that declines in our customer’s operations would result in a sustained reduction in service revenue for the Company.</p>
CY2024Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
195207000
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
145474000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 6pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 6pt 0pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
177000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29639000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30638000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6314000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8419000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
8419000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
94485000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
98031000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
94634000
CY2024Q1 us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
159000
CY2024Q1 us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
308000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
94485000
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-56000
CY2023Q1 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
119000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
50632000
CY2024Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
26916000
CY2024Q1 lope Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Two
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearTwo
9747000
CY2024Q1 lope Debt Securities Available For Sale Fair Value Maturity Allocated And Single Maturity Date Year Three
DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateYearThree
7190000
CY2024Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
94485000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29459000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30461000
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
180000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
349107000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
340114000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
176921000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
170415000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
172186000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
169699000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
210280000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
44004000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
166276000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
8419000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
8419000
CY2024Q1 lope Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
126286000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
166276000
CY2024Q1 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
3877000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
3018000
CY2024Q1 lope Lessee Operating Lease Lease Not Yet Commenced Commitment Amount
LesseeOperatingLeaseLeaseNotYetCommencedCommitmentAmount
29578000
CY2024Q1 lope Number Of Off Campus Classroom And Laboratory Sites
NumberOfOffCampusClassroomAndLaboratorySites
5
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M14D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
3541000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2600000
CY2024Q1 lope Number Of Financing Leases
NumberOfFinancingLeases
0
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
11025000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
14808000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
14808000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
14080000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13835000
CY2024Q1 lope Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
45261000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
113817000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16520000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
97297000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3483000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3369000
CY2024Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
871000
CY2023Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
842000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2612000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2527000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001558370-24-007046-index-headers.html Edgar Link pending
0001558370-24-007046-index.html Edgar Link pending
0001558370-24-007046.txt Edgar Link pending
0001558370-24-007046-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lope-20240331.xsd Edgar Link pending
lope-20240331x10q.htm Edgar Link pending
lope-20240331xex31d1.htm Edgar Link pending
lope-20240331xex31d2.htm Edgar Link pending
lope-20240331xex32d1.htm Edgar Link pending
lope-20240331xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
lope-20240331x10q_htm.xml Edgar Link completed
lope-20240331_cal.xml Edgar Link unprocessable
lope-20240331_lab.xml Edgar Link unprocessable
lope-20240331_pre.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lope-20240331_def.xml Edgar Link unprocessable